Gossamer Bio Quote - GOSS

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.7001

Bid

0.7001

Offer

0.7012

Volume

491,447

0.6801 Day's Range 0.7097

0.4993 52 Week Range 1.60

Market Cap

158.646M

Previous Close

0.70

Open

0.69

Last Trade

0.70065

Last Trade Time

05:48:42

Financial Volume

US$ 343,612

VWAP

0.699184

Average Volume (3m)

920,267

Shares Outstanding

226,604,137

Dividend Yield

PE Ratio

-0.88

Earnings Per Share (EPS)

-0.79

Revenue

Net Profit

-179.82M

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gossamerbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Gossamer Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOSS. The last closing price for Gossamer Bio was US$0.70. Over the last year, Gossamer Bio shares have traded in a share price range of US$ 0.4993 to US$ 1.60.

Gossamer Bio currently has 226,604,137 shares in issue. The market capitalisation of Gossamer Bio is US$158.62 million. Gossamer Bio has a price to earnings ratio (PE ratio) of -0.88.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0001	0.0142857142857	0.7	0.7314	0.6801	981434	0.71625153	CS
4	-0.1805	-20.4973881444	0.8806	0.9158	0.6617	1136958	0.75070054	CS
12	-0.2099	-23.0659340659	0.91	1.11	0.6617	920267	0.87802305	CS
26	0.1201	20.7068965517	0.58	1.37	0.4993	1466241	0.86061284	CS
52	-0.1296	-15.6201036519	0.8297	1.6	0.4993	1461976	0.92146518	CS
156	-9.6499	-93.2357487923	10.35	15.195	0.4525	1997915	3.03381798	CS
260	-24.7399	-97.2480345912	25.44	27.1497	0.4525	1435694	4.4778827	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CYCNCyclerion Therapeutics Inc	US$ 7.2136 (348.05%)	115.72M
SMXSMX Security Matters Public Company	US$ 0.512549 (163.12%)	457.13M
CNEYCN Energy Group Inc	US$ 0.593026 (87.90%)	155.23M
SRMSRM Entertainment Inc	US$ 1.1208 (77.88%)	133.89M
HTOOFusion Fuel Green PLC	US$ 0.559 (75.79%)	267.09M
RLMDRelmada Therapeutics Inc	US$ 0.643 (-76.79%)	14.06M
MIGIMawson Infrastructure Group Inc	US$ 0.8422 (-55.91%)	10.9M
MONDMondee Holdings Inc	US$ 0.1998 (-32.29%)	2.58M
ORISOriental Rise Holdings Ltd	US$ 8.48 (-29.04%)	507.23k
FGLFounder Group Limited	US$ 2.95 (-27.70%)	9.79M
SMXSMX Security Matters Public Company	US$ 0.512549 (163.12%)	457.13M
SVMHSRIVARU Holding Ltd	US$ 0.0267 (21.36%)	438.3M
HTOOFusion Fuel Green PLC	US$ 0.559 (75.79%)	267.09M
CNEYCN Energy Group Inc	US$ 0.593026 (87.90%)	155.23M
SRMSRM Entertainment Inc	US$ 1.1208 (77.88%)	133.89M